22
MAY 15, 2023
Smoke Signals
find your path
ELIG IB ILITY
÷
AGE REQUIREMENT
Candidates must be at least
18 years in age .
÷ TRIBAL PREFERENCE
Tribal Preference applies.
However, nonTribal
candidates can be
considered based on
business need, certifications
and skills required.
÷ AVAILABILITY
Most positions work Monday
through Friday 8 a.m. to 5
p.m. Part-time and full-time
work is available. Specific
schedules will be
communicated upon job
placement. Candidates will
be expected to adhere to
work and schedule
requirements.
AREYOULOOKINGFORANOPPORTUNITY
TOEXPLOREMULTIPLE CAREER PATHS?
AREYOULOOKINGFORAWAYTO DEVELOP
YOURSKILLSANDABILITIESINTHE
WORKPLACE?
APPLYTOTHE CTGR TEMP POOL AND
STARTYOURJOURNEYTODAY!
The CTGR Temp Pool was designed to fill the immediate staffing
needs of CTGR Programs, and provides opportunities for participants
to explore Part-Time and Full-Time job placement opportunities
throughout the campus.
We often have opportunities in the Health & Wellness Clinic, Social
Services, Facilities, Human Resources, TERO, Housing, the MAT
Clinic in Salem, Adult Foster Care, and many more.
Apply online to begin your journey!
APPLY ONINE: https://www.grandronde.org/employment/
LEGAL NOTICE
IF YOU, A CHILD IN YOUR CARE, OR ANOTHER LOVED ONE WERE HARMED BY ENDO
OR A RELATED COMPANY, INCLUDING PAR OR AMS, OR THEIR PRODUCTS INCLUDING
OPIOIDS, RANITIDINE, OR TRANSVAGINAL MESH, YOUR RIGHTS MAY BE AFFECTED
BY DEADLINES IN THE ENDO BANKRUPTCY.
The deadline to file a claim in the bankruptcy is July 7, 2023, at 5:00 p.m. (prevailing Eastern Time).
The deadline to object to Endo’s sale is July 7, 2023, at 4:00 p.m. (prevailing Eastern Time).
WHAT IS THIS ABOUT?
WHAT DO YOU NEED TO KNOW ABOUT THE BAR DATE AND PROOF OF CLAIM PROCESS?
On August 16, 2022, Endo International plc and certain of its affiliates filed for chapter
11 bankruptcy in the United States Bankruptcy Court for the Southern District of New
York. Certain Endo affiliates manufactured and/or sold, among other things, branded opioid
medications (including but not limited to OPANA ® (oxymorphone hydrochloride), OPANA ®
ER (oxymorphone hydrochloride extended release), and PERCOCET ® (oxycodone and
acetaminophen tablets)), generic opioid medications, generic ranitidine medications,
and transvaginal mesh. This notice is intended to inform you of your rights in this
bankruptcy regarding the bar date and proof of claim process and Endo’s proposed
sale of substantially all of its assets.
The deadline to submit your proof of claim is called a bar date. The bar date, or the deadline
to submit your proof of claim, is July 7, 2023, at 5:00 p.m. (prevailing Eastern Time). If you
do not submit a proof of claim by the deadline, you will lose any rights you may have had to seek
payment or compensation. You must file a proof of claim form so that it is actually received by
the bar date. A proof of claim form can be filed by you, a legal guardian, survivors, or relatives of
people who have died or are disabled. You do not need an attorney to file a proof of claim for you.
WHAT IS A CLAIM?
A “claim” means a right to seek payment or other compensation. If you, a child in your care,
or another loved one were harmed by Endo or a related company, including Par or American
Medical Systems (AMS), or their products, including opioids, ranitidine, or transvaginal mesh,
you may have a claim against one or more of these entities. To make a claim, you will need
to submit a proof of claim in the bankruptcy case. You may file a claim on behalf of yourself,
a child in your care (including a child exposed to opioids in the womb), or a deceased or
disabled relative. Examples of claims that may be filed in the Endo bankruptcy include but are
not limited to:
> Opioid Claims: Claims for death, addiction or dependence, lost wages, loss of consortium,
or neonatal abstinence syndrome (sometimes referred to as “NAS”), among others.
> Ranitidine claims: Claims for cancer, including bladder, esophageal, pancreatic, stomach,
and liver cancer, among others.
> Transvaginal mesh claims: Claims for pelvic pain, infection, bleeding, among others.
For a more complete list of relevant companies and products manufactured and/or sold by Endo
and its related companies, including full prescribing information and BOXED WARNINGS for
OPANA ® (oxymorphone hydrochloride), OPANA ® ER (oxymorphone hydrochloride extended
release), and PERCOCET ® (oxycodone and acetaminophen tablets), and for more complete
details about the bar date and instructions on how to file a confidential personal injury claim,
visit EndoClaims.com or call 877.542.1878 (Toll-Free) or 929.284.1688 (International).
WHAT DO YOU NEED TO KNOW ABOUT THE SALE?
Endo intends to sell substantially all of its assets in an auction and sale process in the bankruptcy
case and subject to approval by the bankruptcy court. Endo is seeking relief that the sale will
be free and clear of all claims, liens, and encumbrances.
If you disagree with the proposed sale, you must object to the sale in writing, so that your
objection is received on or before July 7, 2023, at 4:00 p.m. (prevailing Eastern Time). Any
party in interest who fails to properly file and serve its objection by the objection deadline
may lose its claim against Endo’s assets if the sale is approved. Objections not filed and
served properly may not be considered by the bankruptcy court.
Complete details about the proposed sale, including any auction for Endo’s assets, the date of
the hearing to consider the sale, and instructions on how to file an objection, are available at
EndoClaims.com or by calling 877.542.1878 (Toll-Free) or 929.284.1688 (International).
IF YOU HAVE ANY QUESTIONS OR IF YOU WOULD LIKE TO OBTAIN ADDITIONAL INFORMATION:
CALL: 877.542.1878 (Toll-Free)
929.284.1688 (International)
VISIT:
EndoClaims.com
EMAIL:
EndoInquiries@ra.kroll.com
WRITE:
Endo International plc Claims Processing Center
c/o Kroll Restructuring Administration LLC
Grand Central Station, PO Box 4850
New York, NY 10163-4850
Paid ad